Page 41 - manuscript_ijb05596
P. 41

References

                   [1]  Chung WK, Erion K, Florez JC, et al. Precision medicine in diabetes: a consensus report

                       from the american diabetes association (ADA) and the european association for the study
                       of diabetes (EASD). Diabetologia. 2020; 63(9): 1671-1693. doi: 10.2337/dci20-0022.


                   [2]  Zhang J, Lin C, Jin S, et al. The pharmacology and therapeutic role of cannabidiol in
                       diabetes. Explor. 2023; 3(5): 20230047. doi: 10.1002/exp.20230047.

                   [3]  Ogurtsova K, Guariguata L, Barengo NC, et al. IDF diabetes Atlas: global estimates of

                       undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pr. 2022; 183: 109118. doi:

                       10.1016/j.diabres.2021.109118.

                   [4]  Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates

                       for  2019  and  projections  for  2030  and  2045:  results  from  the  international  diabetes

                       federation  diabetes  Atlas,  9th  edition.  Diabetes  Res  Clin  Pr.  2019;  157:  107843.  doi:

                       10.1016/j.diabres.2019.107843.

                   [5]  Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes

                       prevalence for 2017 and projections for 2045. Diabetes Res Clin Pr. 2018; 138:271-281.

                       doi: 10.1016/j.diabres.2018.02.023.
                   [6]  Verma  AK,  Goyal  Y,  Bhatt  D,  et  al.  A  compendium  of  perspectives  on  diabetes:  a


                       challenge for sustainable health in the modern Era. Diabetes Metab Syndr Obes. 2021; 14:
                       2775-2787. doi: 10.2147/dmso.s304751.

                   [7]  Kirsner RS, Yosipovitch G, Hu S, et al. Diabetic skin changes can benefit from moisturizer

                       and  cleanser  use:  a  review.  J  Drugs  Dermatol.  2019;  18(12):  1211-1217.  doi:

                       10.1002/advs.202201425.

                   [8]  Kartika RW, Alwi I, Suyatna FD, et al. The role of VEGF, PDGF and IL-6 on diabetic

                       foot ulcer after Platelet Rich Fibrin hyaluronic therapy. Heliyon. 2021; 7(9): e07934. doi:

                       10.1016/j.heliyon.2021. e07934.

                   [9]  Sharifiaghdam M, Shaabani E, Faridi-Majidi R, et al. Macrophages as a therapeutic target

                       to  promote  diabetic  wound  healing.  Mol  Ther.  2022;  30(9):  2891-2908.  doi:

                       10.1016/j.ymthe.2022.07.016.

                   [10] Kamal R, Awasthi A, Pundir M, et al. Healing the diabetic wound: Unlocking the secrets

                       of   genes   and   pathways.   Eur   J   Pharmacol.   2024;   975:176645.   doi:
                                                            40
   36   37   38   39   40   41   42   43   44   45   46